Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/XOMA Royalty Corporation/ 10-Q

Quarterly Report · 10-Q

XOMA Royalty Corporation

Quarterly Report

Filed May 12, 2026Accepted May 12, 2026, 4:06 PM EDTCIK 791908Accession 0001104659-26-059369
View company →Permanent SEC source ↗
Share

Company context

XOMA Royalty is a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health. XOMA Royalty acquires the potential future economics associated with pre-commercial and commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA Royalty acquires the future economics, the seller receives non-dilutive, non-recourse funding they can use to advance their internal drug candidate(s) or for general corporate purposes. XOMA Royalty has an extensive and growing portfolio of assets (asset defined as the right to receive potential future economics associated with the advancement of an underlying therapeutic candidate). For more information about XOMA Royalty and its portfolio, please visit www.xoma.com or follow XOMA Royalty Corporation on LinkedIn.

Historical securities (3)
XOMANASDAQ · EQUITY · Historical · closed Jul 14, 2026XOMAONASDAQ · PREFERRED · Historical · closed Jul 14, 2026XOMAPNASDAQ · PREFERRED · Historical · closed Jul 14, 2026

Recent company filings

  1. SCHEDULE 13G/A - filed by MORGAN STANLEY regarding XOMA Royalty CorpAug 7, 2026
  2. SCHEDULE 13G/A - filed by MORGAN STANLEY regarding XOMA Royalty CorpAug 7, 2026
  3. SCHEDULE 13G/A - filed by VANGUARD CAPITAL MANAGEMENT LLC regarding XOMA Royalty CorpJul 31, 2026
  4. SCHEDULE 13G/A - filed by BlackRock, Inc. regarding XOMA Royalty CorpJul 30, 2026
  5. 15-12G filingJul 27, 2026

Registered securities in this filing

XOMA Royalty Corporation · 10-Q · Filed 2026-05-12

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.0075

Symbol
XOMA
Exchange
NASDAQ
Classification
COMMON
Status
Historical · closed Jul 14, 2026
Filing context

Context: Duration_1_1_2026_To_3_31_2026_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember_tQ36wpyMoU2TMXn3TrdHbg

Dimensions: us-gaap:StatementClassOfStockAxis

8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05

Symbol
XOMAP
Exchange
NASDAQ
Classification
PREFERRED
Status
Historical · closed Jul 14, 2026
Filing context

Context: Duration_1_1_2026_To_3_31_2026_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember_cUECyaEW90Omfxet12rVSw

Dimensions: us-gaap:StatementClassOfStockAxis

Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05)

Symbol
XOMAO
Exchange
NASDAQ
Classification
PREFERRED
Status
Historical · closed Jul 14, 2026
Filing context

Context: Duration_1_1_2026_To_3_31_2026_us-gaap_StatementClassOfStockAxis_dei_AdrMember_P8SV27Euq0SLckQjBRJjTA

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000110465926059369 · 3 registered-security cover members

Read the exact SEC filing ↗

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.